These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2872310)

  • 1. Pharmacological activity of amantadine: effect of N-alkyl substitution.
    Dunn JP; Henkel JG; Gianutsos G
    J Pharm Pharmacol; 1986 May; 38(5):353-6. PubMed ID: 2872310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of amantadine and amfonelic acid on dopamine metabolism in rat brain.
    Fuller RW; Snoddy HD; Perry KW
    Brain Res Bull; 1981 Feb; 6(2):141-3. PubMed ID: 7470959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine.
    Gianutsos G; Chute S; Dunn JP
    Eur J Pharmacol; 1985 Apr; 110(3):357-61. PubMed ID: 2861102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine.
    Peeters M; Page G; Maloteaux JM; Hermans E
    Brain Res; 2002 Sep; 949(1-2):32-41. PubMed ID: 12213297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased dopamine uptake in striatal synaptosomes after treatment of rats with amantadine.
    Page G; Peeters M; Maloteaux JM; Hermans E
    Eur J Pharmacol; 2000 Sep; 403(1-2):75-80. PubMed ID: 10969146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse strain-dependent effect of amantadine on motility and brain biogenic amines.
    Messiha FS
    Arch Int Pharmacodyn Ther; 1989; 302():74-85. PubMed ID: 2484011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-anti-Parkinson activity relationships in the aminoadamantanes. Influence of bridgehead substitution.
    Henkel JG; Hane JT; Gianutsos G
    J Med Chem; 1982 Jan; 25(1):51-6. PubMed ID: 7086822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined effect of amphetamine and midantan on the dopaminergic transmission in the striatum of freely moving rats].
    Afanas'ev II; Dvorkina ML; Raevskiĭ KS
    Eksp Klin Farmakol; 2003; 66(1):3-7. PubMed ID: 12683071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM; Lane JD; Brauchi JT
    Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine and catecholamine uptake.
    Herblin WF
    Biochem Pharmacol; 1972 Jul; 21(14):1993-5. PubMed ID: 4649347
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of delta and mu opiopeptides on the turnover and release of dopamine in rat striatum.
    Yonehara N; Clouet DH
    J Pharmacol Exp Ther; 1984 Oct; 231(1):38-42. PubMed ID: 6092604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific long-term effects of amphetamine on striatal dopamine neurons in rats.
    Steranka LR
    Eur J Pharmacol; 1981 Dec; 76(4):443-6. PubMed ID: 7327212
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of sulfonium analogues of dopamine: nonclassical dopamine agonists.
    Anderson K; Kuruvilla A; Uretsky N; Miller DD
    J Med Chem; 1981 Jun; 24(6):683-7. PubMed ID: 7252978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat.
    Scavone C; De Lucia R; Bernardi MM; Aizenstein ML
    Eur J Pharmacol; 1985 May; 112(1):11-6. PubMed ID: 4040467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.
    Bariletto S; Dollar E; Leitz F
    J Neurochem; 1975 Aug; 25(2):139-42. PubMed ID: 1141911
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane.
    Warnick JE; Maleque MA; Bakry N; Eldefrawi AT; Albuquerque EX
    Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites.
    Koch SW; Koe BK; Bacopoulos NG
    Eur J Pharmacol; 1983 Sep; 92(3-4):279-83. PubMed ID: 6138267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.
    Karobath ME
    Eur J Pharmacol; 1974 Oct; 28(2):376-8. PubMed ID: 4424404
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the mechanism of action of amantadine.
    Brown F; Redfern PH
    Br J Pharmacol; 1976 Dec; 58(4):561-7. PubMed ID: 1000133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacological profile of a new series of dopamine agonists: N-n-propyl-hexahydronaphthoxazines.
    Hazelhoff B; De Vries JB; Dijkstra D; Mulder TB; Timmermans PB; Wynberg H; Horn AS
    Eur J Pharmacol; 1986 May; 124(1-2):93-106. PubMed ID: 3720849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.